longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesLongbridge ProFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

Allist

688578

81.793.16% ( -2.67 )
Delay Closed: Oct 16, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
  • Report Says Germany Urges EU to Impose Import Quotas on More Chinese Goods

    AASTOCKS News·Oct 14, 2026 at 08:35 AM
  • JPM Maintains CSI 300 Target at 5,200 by End-2026, Continues to Favor Barbell Investment Strategy

    AASTOCKS News·Oct 14, 2026 at 06:55 AM
  • China’s NMPA clears Foresee’s Camcevi 42 mg for prostate cancer

    Pharmaceutical Technology·Oct 13, 2026 at 09:27 AM
  • JPM: China Biotech ESMO Catalysts May Validate Domestic Innovation; Top Picks SKB BIO , INNOVENT BIO

    AASTOCKS News·Oct 13, 2026 at 07:05 AM
    01801+1.48%09926+0.94%
  • 12 Health Care Stocks Moving In Monday's Intraday Session

    benzinga_article·Oct 12, 2026 at 05:05 PM
    APLM+0.48%CLGN-1.49%
  • Foresee Pharma's Partner GenSci To Launch CAMCEVI 42 Mg In China

    rttnews·Oct 12, 2026 at 07:35 AM
  • TikTok CEO sees major scientific breakthroughs from AI within three years

    CNBC·Oct 12, 2026 at 04:24 AM
  • Allist Slumps After Star Lung Cancer Drug Fails in Overseas Clinical Trial

    Yicai·Oct 8, 2026 at 11:19 AM
    AVBP-0.77%688578-3.16%
  • Chinese biotech faces reality check as ArriVent drug failure sinks stock in US

    SCMP·Oct 7, 2026 at 11:41 AM
    AVBP-0.77%688578-3.16%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy